Correlation Between X4 Pharmaceuticals and Iovance Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Iovance Biotherapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Iovance Biotherapeutics.
Diversification Opportunities for X4 Pharmaceuticals and Iovance Biotherapeutics
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between XFOR and Iovance is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Iovance Biotherapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Iovance Biotherapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 3.09 times more return on investment than Iovance Biotherapeutics. However, X4 Pharmaceuticals is 3.09 times more volatile than Iovance Biotherapeutics. It trades about 0.02 of its potential returns per unit of risk. Iovance Biotherapeutics is currently generating about -0.09 per unit of risk. If you would invest 50.00 in X4 Pharmaceuticals on August 30, 2024 and sell it today you would lose (11.00) from holding X4 Pharmaceuticals or give up 22.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Iovance Biotherapeutics
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Iovance Biotherapeutics |
X4 Pharmaceuticals and Iovance Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Iovance Biotherapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.| X4 Pharmaceuticals vs. Ikena Oncology | X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. HCW Biologics | X4 Pharmaceuticals vs. RenovoRx |
| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |